Back to search

University of Sheffield

Investigating the roles of endoglin in cardiovascular development, disease and repair

Abstract

dc:description.abstract

Objective: ENG or ALK1 heterozygous loss of function mutations lead to the human disease hereditary haemorrhagic telangiectasia. HHT is characterised by the development of arteriovenous malformations (AVMs). These form when arteries and veins directly connect without an intermediary capillary system. Large AVMs may occur in the lungs, liver and brain, leading to severe morbidity. There is growing evidence that targeting VEGFA signalling has a benefit in HHT. However, inhibiting VEGFA can have serious adverse effects. Aims: Zebrafish embryos have a number of advantages for drug evaluation, including rapid cardiovascular development, ease of drug administration and transgenic models for imaging. VEGFA signalling is complex and has numerous downstream pathways. I therefore hypothesised that selectively targeting individual pathway(s) downstream of VEGFA may be beneficial in a previously-generated zebrafish genetic model of HHT caused by homozygous mutation of endoglin (engmu130). I first characterised the cardiovascular phenotype of engmu130 embryos and adults in vascular territories not previously examined, including the cerebral vessels, skin, heart and retina. I then tested my hypothesis by treating zebrafish engmu130 mutant and wildtype embryos with drugs that inhibit global VEGFA signalling or different pathways downstream of VEGFR2. Results and conclusions: eng mutant embryos displayed a range of previously undescribed vascular defects, including an aneurysmal basilar artery (BA), while adult mutants developed skin AVMs, retinal vascular abnormalities, and cardiac enlargement. VEGF receptor tyrosine kinase inhibition prevented the vascular abnormalities in eng mutant embryos. Combined subtherapeutic TOR and MEK inhibition prevented the vascular abnormalities, confirming synergy between TOR and MEK/ERK signalling pathways. These results indicate the HHT-like phenotype in zebrafish eng mutants can be mitigated through modulation of VEGFA signalling, and suggest combined low dose MEK and TOR pathway inhibitors may represent a therapeutic strategy in HHT.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Sheffield
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Snodgrass, Ryan Oliver
Advisors dc:contributor.advisor
  • Tim, Chico
  • Helen, Arthur
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.858818

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Snodgrass, Ryan Oliver. Investigating the roles of endoglin in cardiovascular development, disease and repair. doctoral thesis, University of Sheffield, 2022.